Metropolis Healthcare's Q2 FY 2025-26 Quarterly Results

Result Summary

• Metropolis Healthcare Ltd reported a 9.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 21.9%.
• Its expenses for the quarter were up by 8.0% QoQ and 23.2% YoY.
• The net profit increased 16.9% QoQ and increased 13.3% YoY.
• The earnings per share (EPS) of Metropolis Healthcare Ltd stood at 10.13 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Metropolis Healthcare Ltd is a leading diagnostic service provider in India, offering a wide array of tests and health check-ups. The company operates a chain of diagnostic centers across the country, providing laboratory services that include pathology and radiology tests. Metropolis is known for its advanced technology and quality assurance processes, ensuring accurate and timely diagnostics for patients. Recent developments in the company include expanding its service portfolio and geographical reach through strategic partnerships and acquisitions. However, specific recent events or changes in the company’s operations are not available from the provided data.

Revenue

In Q2FY26, Metropolis Healthcare Ltd reported a total income of ₹430.08 crores. This represents a quarter-over-quarter (QoQ) increase of 9.3% compared to Q1FY26, where the total income was ₹393.58 crores. Year-over-year (YoY) growth was significant at 21.9% from Q2FY25, where the total income stood at ₹352.92 crores. This upward trend in revenue highlights the company's capacity to enhance its income streams over both the short and long term. The increase in total income is a crucial metric reflecting the company's performance in the healthcare diagnostics sector.

Profitability

For Q2FY26, Metropolis Healthcare Ltd achieved a profit before tax of ₹71.03 crores, marking a QoQ growth of 16.0% from ₹61.23 crores in Q1FY26. The YoY growth in profit before tax was 15.7% from ₹61.40 crores in Q2FY25. After accounting for taxes of ₹18.14 crores, the profit after tax for Q2FY26 was ₹52.89 crores. This profit after tax indicates a 16.9% increase QoQ and a 13.3% increase YoY. The company's earnings per share (EPS) rose to ₹10.13 in Q2FY26, reflecting a QoQ growth of 17.0% from ₹8.66 and a YoY growth of 12.2% from ₹9.03. These profitability metrics demonstrate the company's ability to maintain and enhance its earnings.

Operating Metrics

The total expenses for Metropolis Healthcare Ltd in Q2FY26 were ₹359.06 crores, rising 8.0% from ₹332.36 crores in Q1FY26, and 23.2% from ₹291.52 crores in Q2FY25. The tax expenses for Q2FY26 increased by 13.4% QoQ from ₹15.99 crores and 23.4% YoY from ₹14.70 crores. These figures illustrate the company's operational cost dynamics and their impact on net profitability. While specific financial ratios such as P/E ratio, debt-to-equity ratio, or current ratio are not provided, the available data points to a detailed picture of the company's financial management and operational efficiency. Significant trends in operating expenses and tax obligations are crucial elements reflecting the company's business operations.